Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This study will assess the pharmacokinetic profile and the safety/tolerability profile of
single and monthly doses of pasireotide LAR intramuscular (i.m.) injection in patients with
acromegaly and patients with carcinoid disease